Ginseng :: Ginseng helps cancer patients, reduces fatigue
American ginseng provides greater improvements in fatigue and vitality in patients who receive the highest doses tested, compared to lower doses or no treatment, revealed by researchers.
American ginseng provides greater improvements in fatigue and vitality in patients who receive the highest doses tested, compared to lower doses or no treatment, revealed by researchers.
A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research.
Massey scientists have discovered a weak link in human digestion that could revolutionise healthy eating and medical treatment for the chronically-ill.
University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.
The simple notion of copying the body?s own natural “waste disposal” chemistry to mop up potentially toxic nitrogen has saved an estimated 80 percent of patients with urea cycle disorders — most of them children ? according to a report in this week?s New England Journal of Medicine summarizing a quarter century of experience with the treatment.
Flaxseed, an edible seed that is rich in omega 3-fatty acids and fiber-related compounds known as lignans, is effective in halting prostate tumor growth, according to a study led by Duke University Medical Center researchers.
Higher levels of a protein called S-100 in patients with melanoma may correlate with a higher risk of having the disease return, say researchers at the University of Pittsburgh Cancer Institute (UPCI), who presented their findings today at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
North Central Cancer Treatment Group researchers, based at Mayo Clinic in Rochester, Minn., have generated preliminary data suggesting that a form of American ginseng provides greater improvements in fatigue and vitality in patients who receive the highest doses tested, compared to lower doses or no treatment.
Last year, a groundbreaking international project found that a group of Japanese patients with advanced non-small cell lung cancer survived longer ?and had a higher rate of side effects ? than U.S. patients with the same diagnosis,.when both groups were given two well-known drugs for the disease.